Advertisement

Topics

Teva Pharmaceutical Industries Ltd. & OncoGenex Pharmaceuticals, Inc. Company Profile

04:40 EDT 19th March 2019 | BioPortfolio

OncoGenex is a biopharmaceutical company committed to the development and commercialization of new cancer therapies that address treatment resistance in cancer patients. OncoGenex has a deep oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. OGX-011, the lead candidate that has completed five Phase II clinical trials in prostate, lung and breast cancers, is designed to inhibit the production of a specific protein associated with treatment resistance; OGX-427 is in Phase I clinical development; SN2310 has completed a Phase I clinical trial; and CSP-9222 and OGX-225 are currently in pre-clinical development.


News Articles [1828 Associated News Articles listed on BioPortfolio]

Teva Pharmaceutical Industries Limited Strategy, SWOT and Corporate Finance Report [Report Updated: 28082018] Prices from USD $175

Teva Pharmaceutical Industries Limited Strategy, SWOT and Corporate Finance ReportSummaryTeva Pharmaceutical Industries Limited Strategy, SWOT and Corporate Finance Report, is a source of comprehens...

TEVA Pharmaceutical Industries: Weiterhin im Korrekturmodus!

Im August sah es kurzzeitig so aus, als hätte die Aktie des Generika-Herstellers TEVA Pharmaceutical Industries ihre Konsolidierung beendet und eine neue Anstiegsphase eingeleitet. Der Anstieg auf .....

TEVA Pharmaceutical Industries: Leiten die Käufer jetzt die Wende ein?

Im August stieg die Aktie des Generika-Herstellers TEVA Pharmaceutical Industries auf ein neues Hoch bei 25,96 US-Dollar an und es sah kurzzeitig so aus, als hätte der Wert seine Konsolidierung bee.....

TEVA Pharmaceutical Industries: Fiebrige Ausschläge!

Beim Blick auf den Chart des Generika-Herstellers TEVA Pharmaceutical Industries wird die extreme Anspannung, die die Anleger in den USA in den letzten Tagen erfasst hat, sehr schnell deutlich. Am ...

TEVA Pharmaceutical Industries: Die Käufer sollten die Korrektur jetzt schnell beenden!

Im August stieg die Aktie des Generika-Herstellers TEVA Pharmaceutical Industries auf ein neues Hoch bei 25,96 US-Dollar an und es sah kurzzeitig so aus, als wäre eine neue Anstiegsphase eingeleite.....

TEVA Pharmaceutical Industries: Neue Tiefs voraus

In den letzten beiden Monaten des Jahres 2018 musste die Aktie des Generkia-Herstellers TEVA Pharmaceutical Industries deutliche Verluste hinnehmen, denn bis zum 24. Dezember ermäßigte sich der Kur....

TEVA Pharmaceutical Industries: Jetzt sind die Käufer gefordert!

Die Aktie des Generika-Herstellers TEVA Pharmaceutical Industries bildete am 2. November bei 10,85 US-Dollar ein Tief aus und stieg anschließend bis zum 29. Juni auf 25,14 US-Dollar an. Der Juli un.....

TEVA Pharmaceutical Industries: Kurzfristig könnte es zäh werden!

Die Aktie des Generika-Herstellers TEVA Pharmaceutical Industries wurde im November und Dezember von den Anlegern gnadenlos abverkauft. Bis zum 24. Dezember ermäßigte sich der Kurs auf 14,59 US-Dol....

Drugs and Medications [208 Associated Drugs and Medications listed on BioPortfolio]

Helium [gt industries inc]

helium

Nitrogen [gt industries inc]

nitrogen

Nitrogen [ivey industries]

NITROGEN COMPRESSED NF

Oxygen [ivey industries]

OXYGEN COMPRESSED USP LABEL

Oxygen [ivey industries]

OXYGEN REFRIGERATED LIQUID USP

PubMed Articles [723 Associated PubMed Articles listed on BioPortfolio]

Drug sourcing and motivations among a sample of people involved in the supply of pharmaceutical drugs in Australia.

The non-medical use (NMU) of pharmaceuticals is increasing internationally, along with mortality. Previous research indicates that end-users access pharmaceuticals through social networks, however lit...

Applicability of the electrocoagulation process in treating real municipal wastewater containing pharmaceutical active compounds.

In this study, the viability of using electrocoagulation process as a method for pharmaceuticals removal from real municipal wastewater was demonstrated. Batch experimental runs were performed using a...

Effects of pharmaceuticals on microbial communities and activity of soil enzymes in mesocosm-scale constructed wetlands.

Cyperus alternifolius based mesocosm-scale constructed wetland was employed to remove pharmaceuticals. We investigated the microbial community composition using phosphor lipid fatty acids (PFLAs) anal...

Evaluation of wastewater tracers to predict pharmaceutical distributions and behavior in the Long Island Sound estuary.

Urban estuaries receive large volumes of effluents from municipal wastewater treatment facilities containing numerous contaminants, such as pharmaceuticals residues. Water was sampled for 16 highly pr...

Pharmaceutical residues in streams near concentrated animal feeding operations of Korea - Occurrences and associated ecological risks.

Concentrated animal feeding operations (CAFOs) have been suggested to be the most significant source of pharmaceutical release into the environment. However, limited information is available on the oc...

Clinical Trials [571 Associated Clinical Trials listed on BioPortfolio]

Lansoprazole 30 mg DR Capsule Fasting Study

The object of this study is to compare the relative bioavailability of lansoprazole 30 mg delayed-release capsules (manufactured by TEVA Pharmaceutical Industries, Ltd. and distributed by ...

Lansoprazole 30 mg DR Capsule Fasting Replicate Sprinkle Study

The object of this study is to compare the relative bioavailability of lansoprazole 30 mg delayed-release capsules (manufactured by TEVA Pharmaceutical Industries, Ltd. and distributed by ...

Cilostazol 50 mg Tablets Under Fasting Conditions

This study will compare the relative bioavailability (rate and extent of absorption) of 50 mg Cilostazol Tablets manufactured by TEVA Pharmaceuticals Industries Ltd. and distributed by TEV...

Tamsulosin Hydrochloride 0.4 mg Capsules Under Fed Conditions

The objective of this study is to evaluate the comparative bioavailability between tamsulosin hydrochloride 0.4 mg capsules (Manufactured by Teva Pharmaceutical Industries Ltd.; distribute...

A Relative Bioavailability Study of 200mg/5 mL Azithromycin Oral Suspension Under Fasting Conditions

The study will compare the relative bioavailability (rate and extent of absorption) of 200 mg/5 mL Azithromycin oral suspension manufactured by TEVA Pharmaceutical Industries Ltd.; distrib...

Companies [3652 Associated Companies listed on BioPortfolio]

Teva Pharmaceutical Industries Ltd.

When: Wednesday, June 2, 2010 at 10:30 AM (local UK time)

Teva Pharmaceutical Industries Ltd. & OncoGenex Pharmaceuticals, Inc.

OncoGenex is a biopharmaceutical company committed to the development and commercialization of new cancer therapies that address treatment resistance in cancer patients. OncoGenex...

Teva Neuroscience, Inc.

Teva Pharmaceutical Industries Ltd., headquartered in Israel, is among the top 20 pharmaceutical companies in the world and is the world's leading generic pharmaceutical company. The Company develops,...

Teva Pharmaceutical Industries

Teva Pharmaceutical Industries Ltd. is a global pharmaceutical company specializing in the development, production and marketing of generic and proprietary branded pharmaceuticals and active pharmaceu...

Teva Neuroscience Inc.

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) is a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and...

More Information about "Teva Pharmaceutical Industries Ltd. & OncoGenex Pharmaceuticals, Inc." on BioPortfolio

We have published hundreds of Teva Pharmaceutical Industries Ltd. & OncoGenex Pharmaceuticals, Inc. news stories on BioPortfolio along with dozens of Teva Pharmaceutical Industries Ltd. & OncoGenex Pharmaceuticals, Inc. Clinical Trials and PubMed Articles about Teva Pharmaceutical Industries Ltd. & OncoGenex Pharmaceuticals, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Teva Pharmaceutical Industries Ltd. & OncoGenex Pharmaceuticals, Inc. Companies in our database. You can also find out about relevant Teva Pharmaceutical Industries Ltd. & OncoGenex Pharmaceuticals, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...


Corporate Database Quicklinks



Searches Linking to this Company Record